Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3781 AL 3795

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Insufficient low-level near infrared light penetration challenges the efficacy of transcranial photobiomodulation

Tittelmeier J, Kaub L, Milz S, Kugelmann D, Hof PR, Schmitz C, Nussbaum-Krammer C.

Brain Stimul. 2025 Jul-Aug;18(4):1220-1223. doi: 10.1016/j.brs.2025.07.001. Epub 2025 Jul 2.

The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders

Schindler KA, Torices S, Schurhoff N, Gallo DI, Toborek M.

Adv Drug Deliv Rev. 2025 Sep;224:115645. doi: 10.1016/j.addr.2025.115645. Epub 2025 Jul 2.

Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons

Yadav S, Raj RG.

Neuroscience. 2025 Aug 16;581:1-15. doi: 10.1016/j.neuroscience.2025.07.003. Epub 2025 Jul 2.

Preoperative identification of low-risk patients for major complications after acute hip fracture surgery in geriatric patients: an observational cohort study

de Haan E, de Ronde A, de Jong L, van Rijckevorsel VAJIM; DHFR; Roukema GR.

BMC Musculoskelet Disord. 2025 Jul 4;26(1):590. doi: 10.1186/s12891-025-08720-x.

MFG-E8 in Microglial Regulation: A Review of Basic Research in the Central Nervous System

Li D, Lu W, Wang R, Ma Y.

J Food Sci. 2025 Jul;90(7):e70235. doi: 10.1111/1750-3841.70235.

Waisman Syndrome: A Novel RAB39B Mutation in X-Linked Parkinsonism with Basal Ganglia Calcification and Literatures Review

Zhang J, Zhang L, Shi L.

Mov Disord Clin Pract. 2025 Nov;12(11):2021-2023. doi: 10.1002/mdc3.70219. Epub 2025 Jul 5.

Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases

Al-Kassmy J, Alsalmi M, Kang W, Palayew M, Huot P.

Neurodegener Dis Manag. 2025 Oct;15(5):235-244. doi: 10.1080/17582024.2025.2528557. Epub 2025 Jul 5.

Supports available for apomorphine management: How best to facilitate appropriate usage of apomorphine?

Pirtošek Z.

Parkinsonism Relat Disord. 2025 Sep 30;139 Suppl 1:107934. doi: 10.1016/j.parkreldis.2025.107934. Epub 2025 Jun 25.

High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team DBS

Rolim FPS, Portela DMMC.

Arq Neuropsiquiatr. 2025 Jul;83(7):1-4. doi: 10.1055/s-0045-1808087. Epub 2025 Jul 6.

Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review

Beckers M, Hommel D, Lennaerts H, Stuijt C, Smit P, Bloem BR.

J Parkinsons Dis. 2025 Sep;15(6):1062-1077. doi: 10.1177/1877718X251356896. Epub 2025 Jul 6.

The role of fecal microbiota transplantation in selected neurodegenerative diseases and neurodevelopmental disorders

Sopel A, Szczuciński W, Gosiewski T, Salamon D.

Prz Gastroenterol. 2025;20(2):127-141. doi: 10.5114/pg.2024.146118. Epub 2024 Dec 22.

New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer's Disease: A Review

Chatzipieris FP, Kokkalis A, Georgiou N, Petsas E, Apostolou EV, Vougioukalakis GC, Mavromoustakos T.

ACS Omega. 2025 Jun 16;10(25):26208-26232. doi: 10.1021/acsomega.5c00134. eCollection 2025 Jul 1.

Cysteine string protein α and a link between rare and common neurodegenerative dementias

Rosene MJ, Benitez BA.

NPJ Dement. 2025;1(1):15. doi: 10.1038/s44400-025-00016-0. Epub 2025 Jul 3.

Trusting Your Gut When it Comes to the Origin of Parkinson's Disease

Borghammer P, Van Den Berge N, Skjærbæk C, Horsager J.

Mov Disord. 2025 Aug;40(8):1735-1737. doi: 10.1002/mds.30288. Epub 2025 Jul 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias